Inspire Medical Systems, Inc. (NYSE: INSP) Overview: Analyst Upgrade and Legal Challenges

Core Viewpoint - Inspire Medical Systems, Inc. is recognized for its innovative sleep apnea treatment solutions, particularly the Inspire therapy device, while facing a class action lawsuit that may impact investor sentiment [1][2][5] Company Overview - Inspire Medical Systems specializes in medical solutions for sleep apnea, particularly through its implantable Inspire therapy device [1] - The company's current stock price is $89.87, reflecting a recent increase of 7.92% or $6.60 [3][5] - The market capitalization of Inspire Medical Systems is approximately $2.66 billion, indicating its significant presence in the market [3] Analyst Ratings - Stifel Nicolaus has upgraded Inspire Medical Systems to a "Buy" rating with a price target of $110, suggesting a potential increase of 22.4% from the current stock price [1][5] Legal Challenges - The company is currently involved in a class action lawsuit led by the Schall Law Firm, alleging violations of the Securities Exchange Act of 1934, affecting investors who purchased INSP securities between August 6, 2024, and August 4, 2025 [2][5] - Shareholders who have experienced losses are encouraged to contact the law firm before January 5, 2026 [2] Trading Activity - The trading volume for INSP on the NYSE is 1,073,158 shares, indicating active investor interest despite ongoing legal challenges [4][5] - The stock has fluctuated between $83.37 and $90.55 today, with a yearly high of $216.01 and a low of $70.77 [3]